Results 191 to 200 of about 342,150 (384)

The progress of molecules and strategies for the treatment of HBV infection [PDF]

, 2023
Youlu Pan, Heye Xia, Yanwen He, Shenxin Zeng, Zhengrong Shen, Wenhai Huang   +5 more
openalex   +1 more source

A Simplified Risk Assessment Tool to Predict Post Deceased Donor Liver Transplantation Outcomes: A Single, Highly Experienced Medical Center in Taiwan

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Liver transplantation (LT) is the standard treatment for end‐stage liver disease, yet the gap between the demand for organs and their availability is widening. In Taiwan, the scarcity of deceased donor organs highlights the need for optimized utilization strategies.
Jie‐Lan Jhang, Hao‐Chien Hung, Yin Lai, Jin‐Chiao Lee, Yu‐Chao Wang, Chih‐Hsien Cheng, Tsung‐Han Wu, Chen‐Fang Lee, Ting‐Jung Wu, Hong‐Shiue Chou, Kun‐Ming Chan, Wei‐Chen Lee   +11 more
wiley   +1 more source

Mutations in the Basal Core Promoter and Precore/Core Regions of Hepatitis B Virus in Patients Co-Infected With Human Immunodeficiency Virus

Medical Laboratory Journal, 2016
Background and objectives: Globally, about one third of the population has been infected with Hepatitis B virus (HBV) and more than 400 million people have become chronically infected. Nearly, 20-25% of all carriers develop serious liver diseases such as
Ahmad Hosseinzadeh Adli, Chiman Karami, Sareh Zhand, Reza Talei, Abdolvahab Moradi   +4 more
doaj  

Selection of HBV preS1-binding penta-peptides by phage display [PDF]

, 2014
Yonggang He, Xiaoli Ye, Pierre Tiollais, Jiming Zhang, Junqi Zhang, Jing Liu, Youhua Xie   +6 more
openalex   +1 more source

Host and HBV Interactions and Their Potential Impact on Clinical Outcomes [PDF]

, 2023
Alexis José-Ábrego, Sonia Román, Saúl Laguna-Meraz, Arturo Panduro   +3 more
openalex   +1 more source

The 5‐Methylcytosine RNA Modification in Hepatitis B Virus‐Negative Hepatocellular Carcinoma: Insights From Long‐Read Nanopore Sequencing

Molecular Carcinogenesis, EarlyView.
ABSTRACT 5‐Methylcytosine (m5C) RNA modification contributes to tumor initiation and progression. However, its transcriptome‐wide distribution patterns and biological implications in hepatitis B virus (HBV)‐negative hepatocellular carcinoma (HCC) remain poorly understood.
Tianhan Sun, Liying Zhou, XiaoQing Li, Ryan Xiao, Gaoyuan Sun, Lili Zhang, Yifei Li, Wei Huang, Yayu Li, Lu Kuai, Xuanmei Luo, Hongyuan Cui, Meng Chen   +12 more
wiley   +1 more source

Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling

, 2017
Remco Bouckaert, Brenna C. Simons, Henrik Krarup, T. Max Friesen, Carla Osiowy   +4 more
openalex   +1 more source

Incidence and Mortality Risks of Gastrointestinal Cancers During Working‐Age Period: Trends and Disparities in 204 Countries and Territories (1990–2021)

Med Research, EarlyView.
This comprehensive analysis of gastrointestinal (GI) cancer risk reveals that globally, one in 46 people will develop and one in 73 will die from GI cancers during working age (15–64 years), with 2021 incidence and mortality risks of 2.19% and 1.37%, respectively. Key findings demonstrate striking gender disparities, with males facing nearly double the
Yiming Song, Zhongge Ji, Xunbing Zhang, Qian Liang, Zeyu Li, Xiaojie Huang, Jinnan Chen, Yujie Zhou, Xinyuan Wang, Zhao Li, Liuyi Yang, Yixin Qian, Xiaolu Lin, Qingwei Zhang, Xiaobo Li   +14 more
wiley   +1 more source

Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan

, 2017
Meng‐Hsuan Hsieh, Ming‐Lun Yeh, Tung‐Hung Su, Ta-Wei Liu, Chuang-Feng Huang, Ching‐I Huang, Shu‐Chi Wang, Jee‐Fu Huang, Chia‐Yen Dai, Jia‐Horng Kao, Wan‐Long Chuang, Pei‐Jer Chen, Chun‐Jen Liu, Ming‐Lung Yu   +13 more
openalex   +1 more source

P1‐123: Comparison of hepatitis delta and HBV monoinfection in a real‐world setting [PDF]

, 2018

openalex   +1 more source